Ocular formulation development of innovative novel compounds with superior ocular
Ended Project Grant Awarded Last action
- Award ID
- R43EY023920
- Recipient
-
Pharmacatalyst LLC UEI QS7CSB28N3S5
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $265,419
Award facts
- Assistance listing
- 93.867 Vision Research
- Completion date
- Place of performance
- Chester Springs, PA 19425, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $122,920 | |
| Amendment | -$122,921 | |
| Amendment | $25,000 | |
| Amendment | $25,000 | |
| Original award | $215,420 |
Quick answers
Who received award R43EY023920?
R43EY023920 was awarded to Pharmacatalyst LLC by National Institutes of Health (Department of Health and Human Services) on February 1, 2014.
How much is award R43EY023920 worth?
$265,419 has been obligated on R43EY023920.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award